142 related articles for article (PubMed ID: 19949375)
41. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G
Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316
[TBL] [Abstract][Full Text] [Related]
42. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
[TBL] [Abstract][Full Text] [Related]
43. The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis.
Zamin I; Mattos AA; Mattos AZ; Coral G; Santos D; Rhoden C
Arq Gastroenterol; 2010; 47(1):86-92. PubMed ID: 20520981
[TBL] [Abstract][Full Text] [Related]
44. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.
Marcolin E; San-Miguel B; Vallejo D; Tieppo J; Marroni N; González-Gallego J; Tuñón MJ
J Nutr; 2012 Oct; 142(10):1821-8. PubMed ID: 22915297
[TBL] [Abstract][Full Text] [Related]
45. Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice.
Chen R; Wang Q; Song S; Liu F; He B; Gao X
Eur J Pharmacol; 2016 Jan; 770():126-33. PubMed ID: 26593434
[TBL] [Abstract][Full Text] [Related]
46. Myeloid- and hepatocyte-specific deletion of group VIA calcium-independent phospholipase A2 leads to dichotomous opposing phenotypes during MCD diet-induced NASH.
Jansakun C; Chunglok W; Altamura S; Muckenthaler M; Staffer S; Tuma-Kellner S; Merle U; Chamulitrat W
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166590. PubMed ID: 36334837
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of hepatic p63 ameliorates steatohepatitis with fibrosis in mice.
Fondevila MF; Novoa E; Fernandez U; Dorta V; Parracho T; Kreimeyer H; Garcia-Vence M; Chantada-Vazquez MP; Bravo SB; Porteiro B; Cabaleiro A; Koning M; Senra A; Souto Y; Verheij J; Guallar D; Fidalgo M; Meijnikman AS; da Silva Lima N; Dieguez C; Gonzalez-Rellan MJ; Nogueiras R
Mol Metab; 2024 Jul; 85():101962. PubMed ID: 38815625
[TBL] [Abstract][Full Text] [Related]
48. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
Rivera CA; Gaskin L; Allman M; Pang J; Brady K; Adegboyega P; Pruitt K
BMC Gastroenterol; 2010 May; 10():52. PubMed ID: 20509914
[TBL] [Abstract][Full Text] [Related]
49. The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Koca SS; Bahcecioglu IH; Poyrazoglu OK; Ozercan IH; Sahin K; Ustundag B
Inflammation; 2008 Apr; 31(2):91-8. PubMed ID: 18066656
[TBL] [Abstract][Full Text] [Related]
50. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
[TBL] [Abstract][Full Text] [Related]
51. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
52. Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-fed db/db mice.
Yamaguchi K; Itoh Y; Yokomizo C; Nishimura T; Niimi T; Umemura A; Fujii H; Okanoue T; Yoshikawa T
Lab Invest; 2011 Apr; 91(4):609-18. PubMed ID: 21321532
[TBL] [Abstract][Full Text] [Related]
53. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
[TBL] [Abstract][Full Text] [Related]
54. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.
Haque JA; McMahan RS; Campbell JS; Shimizu-Albergine M; Wilson AM; Botta D; Bammler TK; Beyer RP; Montine TJ; Yeh MM; Kavanagh TJ; Fausto N
Lab Invest; 2010 Dec; 90(12):1704-17. PubMed ID: 20548286
[TBL] [Abstract][Full Text] [Related]
55. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice.
McCuskey RS; Ito Y; Robertson GR; McCuskey MK; Perry M; Farrell GC
Hepatology; 2004 Aug; 40(2):386-93. PubMed ID: 15368443
[TBL] [Abstract][Full Text] [Related]
56. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model.
Veteläinen R; van Vliet A; van Gulik TM
J Gastroenterol Hepatol; 2007 Sep; 22(9):1526-33. PubMed ID: 17716355
[TBL] [Abstract][Full Text] [Related]
57. A compromised liver alters polychlorinated biphenyl-mediated toxicity.
Wahlang B; Perkins JT; Petriello MC; Hoffman JB; Stromberg AJ; Hennig B
Toxicology; 2017 Apr; 380():11-22. PubMed ID: 28163111
[TBL] [Abstract][Full Text] [Related]
58. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
dela Peña A; Leclercq IA; Williams J; Farrell GC
J Hepatol; 2007 Feb; 46(2):304-13. PubMed ID: 17157947
[TBL] [Abstract][Full Text] [Related]
59. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T
Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
[TBL] [Abstract][Full Text] [Related]
60. Prolyl endopeptidase disruption reduces hepatic inflammation and oxidative stress in methionine-choline-deficient diet-induced steatohepatitis.
Zhang J; Jiang D; Lin S; Cheng Y; Pan J; Ding W; Chen Y; Fan J
Life Sci; 2021 Apr; 270():119131. PubMed ID: 33516698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
